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Migration of antibody secreting cells towards CXCL12 depends
on the isotype that forms the BCR
Abstract
Truncation of the cytoplasmic tail of membrane-bound IgE in vivo results in lower serum IgE levels,
decreased numbers of IgE-secreting plasma cells and the abrogation of specific secondary immune
responses. Here we present mouse strain KN1 that expresses a chimeric epsilon-gamma1 BCR,
consisting of the extracellular domains of the epsilon gene and the transmembrane and cytoplasmic
domains of the gamma1 gene. Thus, differences in the IgE immune response of KN1 mice reflect the
influence of the "gamma1-mediated signalling" of mIgE bearing B cells. KN1 mice show an increased
serum IgE level, resulting from an elevated number of IgE-secreting cells. Although the primary IgE
immune response in KN1 mice is inconspicuous, the secondary response is far more robust. Most
strikingly, IgE-antibody secreting cells with "gamma1-signalling history" migrate more efficiently
towards the chemokine CXCL12, which guides plasmablasts to plasma cell niches, than IgE-antibody
secreting cells with WT "epsilon-signalling history". We conclude that IgE plasmablasts have an
intrinsic, lower chance to contribute to the long-lived plasma cell pool than IgG1 plasmablasts.
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Summary 
 
 
Truncation of the cytoplasmic tail of membrane-bound IgE in vivo results in lower serum IgE 
levels, decreased numbers of IgE-secreting plasma cells and the abrogation of specific 
secondary immune responses. Here we present mouse strain KN1, which expresses a chimeric 
ε−γ1 B cell receptor, consisting of the extracellular domains of the ε gene and the 
transmembrane and cytoplasmic domains of the γ1 gene. Thus, differences in the IgE immune 
response of KN1 mice reflect the influence of the “γ1-mediated signalling” of mIgE bearing B 
cells. KN1 mice show an increased serum IgE level, resulting from an elevated number of 
IgE-secreting cells. Whereas the primary IgE immune response in KN1 mice is 
inconspicuous, the secondary response is far more robust. Most strikingly, IgE-antibody 
secreting cells with “γ1-signalling history” migrate more efficiently towards the chemokine 
CXCL12, which guides plasmablasts to plasma cell niches, than IgE-antibody-secreting- cells 
with wild type “ε- signalling history”. We conclude that IgE plasmablasts have an intrinsic, 
lower chance to contribute to the long-lived plasma cell pool than IgG1 plasmablasts. 
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Introduction 
 
 Serum antibodies, in particular the isotypes other than IgM, bear the individual 
humoral immunological memory. They are produced by plasma cells, relatively long-lived 
cells, that integrate the recent immunological history into a longer-lasting, protective shield 
[1, 2]. Unfortunately, in predisposed individuals, they also perpetuate the production of 
unwanted, harmful antibodies, like IgE in allergy and autoantibodies in autoimmune diseases 
[3]. The plasma cell, the final cell type in a long B-cell differentiation process, can be 
identified based on the expression of specific markers. Several markers that are specific for 
the B cell lineage, are down regulated upon plasma cell differentiation, including major 
histocompatibility complex class II, CD19, CD21, CD22 and CD45 [4]. In contrast, the 
proteoglycan syndecan-1 (syn-1 or CD138) is up regulated and serves as an identifying 
surface marker for plasma cells. Although some plasma cells persist in the spleen, most of 
them return to their “place of birth” and home to the bone marrow or inflamed tissues where 
they persist for up to several months in survival niches as resident, immobile cells [5, 6]. 
Longevity of the plasma cell is influenced by a broad panel of stimuli, including cytokines 
like IL-5, IL-6, TNF-alpha, GM-CSF and, also, the chemokine CXCL12 [7, 8]. It is believed 
that the contact with stroma cells in the bone marrow provides further adhesion-dependent 
signals supporting plasma cell longevity [9]. The lifespan of plasma cells is limited by the 
immigration of newly formed migratory plasmablasts that compete with old plasma cells for 
space in the survival niches [3].  
 The migration of plasmablasts to the bone marrow is a critical differentiation step to 
long-lived plasma cells. Chemokines and their receptors are crucially involved in the control 
of lymphocyte trafficking. Hauser et al. [10, 11] showed that migratory plasmablasts lose 
responsiveness to many chemokines. The expression of the chemokine receptors CXCR5 and 
CCR7 is decreased on plasma cells, which impairs their migration to B and T cell zones in 
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secondary lymphoid organs [12]. On the other hand, the chemokine receptor CXCR4 is highly 
expressed, guiding the plasma cells into CXCL12 (stromal cell derived factor 1-alpha)-
expressing organs, including splenic red pulp, lymph nodes and bone marrow [13]. 
Muehlinghaus et al. [14] first noticed the importance of the B cell receptor (BCR) in 
modulating the migration behaviour of memory B cells and showed that the chemokine 
receptor CXCR3 was preferentially expressed on a fraction of human memory B cells that 
also expressed mIgG1. 
 The functional importance of the BCR in the generation of humoral immunological 
memory became apparent in experiments in which γ1 and ε cytoplasmic tails were deleted in 
the mouse germ line, and a profound deficiency in the development of IgG1- or IgE-antibody 
responses was observed [15, 16]. Truncation of the IgE and IgG1 cytoplasmic tail diminished 
the secretion of antigen-specific IgE or IgG1 by >10–50-fold during primary and secondary 
immune responses, showing that the tail is necessary for a memory response. These results 
were complemented and extended by a study in which the transgenic expression of a γ1 or 
µ/γ1 hybrid heavy chain together with a transgenic κ light chain which conferred a particular 
antigenic specificity, led to an enhanced generation of memory and plasma cells upon 
antigenic challenge [17, 18]. These in vivo studies clearly established that the cytoplasmic 
tails of class-switched BCRs dramatically enhance or reduce B cell antibody responses, 
although the molecular mechanism remains to be defined. 
 Here we show that the final fate of a plasma cell is determined to a large extent by the 
immunoglobulin isotype that forms the B cell receptor. IgE-Antibody Secreting Cells (ASC) 
carrying a γ1 tail mature faster and migrate more effectively towards a CXCL12 chemokine 
gradient than IgE-ASCs carrying an ε tail. This implies that the isotype specific BCR causes a 
specific functional differentiation, i.e. chemokine receptor sensitivity. We concluded that "γ1-
ness" of the signalling gives the plasma cell a competitive advantage over “ε-ness” in the 
quest for plasma cell niches in the bone marrow.
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Results 
 
IgE-ASCs migrate less efficiently towards a CXCL12 gradient than IgG1-ASCs 
We first investigated the migration behaviour of IgG1-ASCs and IgE-ASCs towards a 
gradient of CXCL9 and CXCL12. IgM-positive cells were enriched from the spleens of three 
normal, wild type mice, using a FITC-labelled rat α-mouse IgM antibody, followed by 
magnetic separation with α-FITC beads. IgM-positive cells were activated with LPS and IL4 
for four days, inducing a class switch to IgG1 or IgE. Equal numbers of activated cells were 
then seeded onto transwell plates. In preparatory experiments, a concentration of 10 nM for 
CXCL12 and 100 nM for CXCL9 was found to be optimal. After 90 min, migrated ASCs 
were collected and counted by ELISpot. The number of potentially migrating ASCs after 
activation, but without exposure to chemokines, served as 100% value. Supplementary 
(Supp.) Figure 1 shows one representative ELISpot analysis of pooled activated cells 
originating from 3 WT mice after migration. Figure 1 shows the statistical analysis of three 
independent experiments with the individual analysis of 3 WT mice each. Migration of IgE- 
and IgG1-ASCs towards CXCL9 was very poor and showed a comparable value of 7% and 
8.75% respectively. This result is in agreement with the data of Muehlinghaus et al. [14] who 
showed that CXCR3neg B cells up-regulate CXCR3 only when they are co-stimulated with 
interferon-γ, but not with IL4. In contrast, migration towards a gradient of CXCL12 was much 
more extensive and significantly differed between IgE-ASCs and IgG1-ASCs. While 54% of 
the IgG1-ASCs actively migrated towards a CXCL12 gradient, only 20% of IgE-ASCs 
migrated within 90 min towards 10nM CXCL12 (Figure 1). These observations suggest that 
the migration behaviour of ASCs is dependent on the immunoglobulin isotype that forms the 
B cell receptor.  
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Construction of Knock-In mouse strain “KN1” 
To validate the observation that IgG1-ASCs more efficiently migrate towards a CXCL12 
gradient than IgE-ASCs we constructed a mouse strain, in which the membrane exons of the ε 
heavy chain gene were replaced by those of the γ1 heavy chain with the technique of 
homologous recombination in embryonic stem cells (see Materials and methods; Suppl. 
Figure 2a). This mouse line, KN1, expresses a chimeric ε−γ1 antigen receptor. Bonafide 
homologous recombination was tested by nested PCR and Southern blot analysis (Suppl. 
Figure 2b). Chimeric mice were crossed with WT BALB/c mice. Heterozygous mice were 
identified by PCR and bred to homozygocity. We feel certain that the downstream 
neomycine-resistance expression cassette, driven by the thymidine kinase promoter, does not 
bias our results. First, it is relatively remote from the γ1 membrane exons; second, reading 
frames are in the same sense and third, Seidl et al. [19] showed that the herpes simplex virus 
thymidine kinase promoter did not influence class switch recombination to upstream constant 
Ig-heavy chain exons. We thus exclude interfering side effects on the phenotypes described 
for KN1. 
 
Continually increasing serum IgE levels in KN1 mice 
We compared the total serum IgE level of five young (8 weeks) and five old (8 months), 
unprimed WT and KN1 mice. In WT young mice, we measured a mean serum IgE level of 
1µg/ml, which increased to 1.7µg/ml in 8 months old mice. KN1 mice showed an increase of 
the mean serum IgE from 1.6 µg/ml in young mice to 6.6 µg/ml in 8 months old mice (Figure 
2a), indicating a 4- to 6-fold elevated mean serum IgE level (***p< 0.0001).  
To determine whether the elevated IgE titres in KN1 were caused by enhanced levels of IgE 
production per cell or by a higher number of cells that produce IgE, we performed individual 
ELISpot analyses of spleen and bone marrow cells (Figure 2b, Suppl. Fig. 3) of the five 8-
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month old mice. The number of IgE-ASCs in the spleen and the bone marrow were in full 
agreement with the serum IgE measurements. In WT mice we counted 16 ( ± 6) IgE-ASCs 
per 106 spleen cells and 8 (± 3) IgE-ASCs per 106 bone marrow cells, while in KN1 66 (± 11) 
IgE-ASCs per 106 spleen cells and 92 (± 16) IgE-ASCs per 106 bone marrow cells were 
detected (Figure 2b). Interestingly, the increase was not equally distributed between spleen 
and bone marrow. When compared to WT, the increase in IgE-ASCs in spleen cells of KN1 
mice was in average 4-fold (**p< 0.001), whereas in the bone marrow the difference was 7 to 
11-fold (**p< 0.001).  
Flowcytometric analysis of B cells in the marrow supported these findings. In young WT 
mice very few, if any CD138+, mIgE+ plasma cells could be detected (Figure 2c, left panel), 
in KN1 a minor fraction of CD138+, mIgEdull cells was found. In contrast, in old (6 month) 
mice, both of KN1 and WT origin, a clear population of CD138+, mIgE+ cells was identified. 
In KN1, but not in WT young mice a CD138-, IgE+ subset of B cells was seen, which we 
consider as being early plasmablasts or IgE memory cells (Figure 2c, right panel). As 
expected, this CD138-, IgE+ subpopulation was present in older (6 month) mice of both 
origins. Always, the MFI, and therewith the mIgE-density of the mIgE+-BCRs on B cells was 
higher on B cells of KN1 mice than on those of WT mice. 
Summarizing, the increased serum IgE level in 8 months old KN1 mice is thus most likely 
explained by the increase in the number of IgE-ASCs in the spleen and the bone marrow of 
these mice.  
 
Increased serum IgE level in KN1 mice is not the result of a different secretion rate 
To determine if the increased IgE titre in KN1 mice is the result of an increased secretion rate, 
IgM-positive B cells were activated as described before. At day 2 and 4, IgE and IgG1 
concentrations were measured in the supernatant of the activated cells (Figure 3a). Thereafter, 
a rapidly beginning cell death prevented further observation. The cells were transferred to 
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Multi-Screen plates and ELISpot analyses for detection of IgG1-ASCs and IgE-ASCs were 
performed (Figure 3b). For IgE, a similar number of IgE-ASCs per 105 activated cells were 
found at day 2 and 4 in WT (80 ± 21 at day 2 and 150 ± 27 at day 4, respectively) and KN1 
(85 ± 25 at day 2 and 132 ± 29 at day 4, respectively) mice, also the amount of IgE in the 
supernatant was comparable in both types of mice. For IgG1, 3-fold more IgG1-ASCs (220 ± 
25 at day 2 and 446 ± 32 at day 4 for WT and 200 ± 50 at day 2 and 436 ± 37 at day 4 for 
KN1), than IgE-ASCs were observed, also reflected in a 2- 3-fold higher concentration of 
IgG1 in the supernatant. There was no indication for different kinetics in the development of 
ASCs and secretion rates of ASCs for the two subclasses in both types of mice. 
We conclude that the amount of immunoglobulin secreted per cell is not different between 
IgG1-ASCs and IgE-ASCs and is therefore independent of the isotype of the membrane 
anchor of the BCR. Equal Ig secretion rates of human plasma cells for all isotypes were also 
reported before [20].  
 
The specific IgE response in KN1 mice is significantly upregulated 
5 WT and 5 KN1 mice were immunized with the T-cell-dependent antigen phenyloxazolone 
coupled to ovalbumin (phOx-OVA). Serum levels of total and specific IgG1 were comparable 
in WT and KN1 mice (Figure 4a,b) during the whole course of immunization. Total IgE 
levels of KN1 mice were not significantly elevated at the beginning of the immunization 
period, but the levels increased at a higher rate in KN1 mice especially after the second 
booster immunization (Figure 4c). phOx-specific IgE antibodies in WT and KN1 mice were 
barely detectable within the first two weeks, which is in agreement with the initial 
development of ASCs, as described in the previous section. However, after the first booster 
immunization titres increased and a clear secondary response, as characterized by a strong and 
fast rise in specific antibody titre, was found (Figure 4d). Comparing the kinetics of the IgE 
response following the booster immunizations (d42 and d181), it is obvious that the IgE 
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response was more robust in KN1 than in WT mice.  
We interpret these observations as reflecting a more efficient development or recruitment of 
IgE-ASCs in general and of IgE-plasma cells in particular in KN1 mice. The boost of specific 
IgE, following the 4th round of immunization, most likely reflects a higher frequency of IgE 
memory cells in KN1 mice. 
 
Chimeric IgE-ASCs develop more efficiently into non-dividing resident plasma cells 
5 WT and 5 KN1 mice per group were immunized i.p. with 10µg of ovalbumin (OVA), 
precipitated in alum. 14 and 21 days later, mice received a booster immunization with 10 µg 
OVA. To determine the number of total and OVA-specific IgE- and IgG1-ASCs, bone 
marrow and spleen were obtained for ELISpot analysis at day 0, 28 and 44 (Figure 5a-h). For 
IgG1, a significant number of antigen-specific ASCs could be detected in spleen and bone 
marrow from day 28 onwards (Figure 5c,d), accompanied by a substantial increase in total 
IgG1-ASCs in both tissues (Figure 5a,b). In KN1, but not in WT mice, a similar and 
significant number of antigen-specific IgE-ASCs was found in spleen and bone marrow on 
day 28 (Figure 5g,h). Later in the response in these mice, the number of IgE-ASCs still 
increased in the bone marrow (Figure 5h), but at a lower pace than the number of IgG1-ASCs 
(Figure 5c,d). In WT mice, antigen-specific IgE-ASCs were only detectable at day 44 in 
spleen, but hardly in bone marrow (Figure 5g,h). A similar pattern was seen when comparing 
KN1 and WT mice for the total number of IgE-ASCs (Figure 5e,f).  
We conclude from these experiments that the presence of a γ1 tail in the BCR causes an 
earlier expansion or recruitment of ASCs to spleen and bone marrow.  
 
Chimeric IgE-ASCs of KN1 resemble the migration behaviour of IgG1-ASCs  
We investigated whether chimeric IgE-ASCs of KN1 mice migrate with comparable speed 
towards a gradient of CXCL12 as do WT IgG1-ASCs. The experiment was performed as 
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described for Figure 1. Equal numbers of activated cells were seeded into transwell plates; the 
number of potentially migrating cells (100%) was set by establishing the number of IgE- and 
IgG1-ASCs without exposure to chemokines. Figure 6a represents the statistical analysis of 3 
WT and 3 KN1 mice. 23 ± 8.9% IgE secreting cells of WT origin and around 60 ± 11.1% IgE 
secreting cells of KN1 origin actively migrated towards a CXCL12 gradient. Thus, the 
chimeric receptor caused a 2.5 fold increase in the number of IgE-ASCs migrating towards 
the CXCL12 gradient. 
Summarizing, the migration frequency of chimeric IgE-ASCs of KN1 mice was significantly 
influenced by the chimeric receptor situation and resembled the migration frequency of WT 
IgG1-ASCs (54 ± 4.6%).  
 
CD138-positive cells from WT and KN1 mice express mIgE at different levels 
To investigate whether quantitative differences in receptor density are responsible for our 
observations, we determined the mIgE antigen receptor expression in WT and KN1 mice. The 
activation protocol was the same as used for the cells that were studied for migration 
behaviour. Frequencies of cell populations were calculated from three independent 
experiments. Figure 6b displays one representative experiment. CD138+, mIgE+ double 
positive cells were found in WT and KN1 mice at a frequency of about 0.8 ± 0.22% for both 
(Quadrants Q2). Remarkably, CD138low, mIgE+ cells, which we consider memory cells or 
early plasmablasts, were found with a higher frequency in KN1 mice (0.3 ± 0.09% in WT and 
0.9 ± 0.15% in KN1 mice, respectively (Quadrants Q3, respectively). Additionally, the mIgE+ 
early plasmablasts of KN1 mice had a higher expression of the (chimeric) IgE-BCR as those 
of WT mice with mean fluorescence intensities (MFI) of 23324 and 17979 for KN1 mice and 
WT mice, respectively.  
Summarizing, (a) CD138low, early plasmablasts express mIgE; (b) In KN1 mice, more 
CD138low, mIgE+ cells arise than in WT mice, (c) CD138low, early plasmablasts of KN1 mice 
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express higher levels of (chimeric) mIgE receptor than WT mice; (d) CD138high plasma cells 
of WT and KN1 mice still express the IgE- and the chimeric-IgE-antigen receptor.  
 
CD138low, mIgE+ B cells of KN1 migrate similar to CD138low, mIgG1+ B cells of WT 
mice 
The quantitatively and qualitatively different expression of mIgE on CD138low, mIgE+ cells in 
KN1 and WT mice raised the questions whether the quality and quantity of the signal induced 
by BCR ligation in this cell type would be different between both mouse strains. We used 
Ca2+ mobilisation as read-out. B cells were activated as in Figure 1; on day 4 of culture the 
responsiveness of CD138low, mIgE+ cells from WT and KN1 mice and CD138low, mIgG1+ 
cells from WT mice, corresponding to the cells in Quadrant Q3 of Figure 6b was tested. We 
consider these cells as being memory B cells and early plasmablasts and consider them 
maximally responsive to BCR ligation. All cell types studied responded to BCR ligation with 
an early Ca2+ flux from intracellular stores (Figure 6c), The early response of CD138low, 
mIgE+ cells from WT and KN1 mice was not apparently different, and lower than the 
response of CD138low, mIgG1+ cells. However, there was a clear difference between chimeric 
mIgE+ cells of KN1 mice and mIgG1+ cells at the one hand and mIgE+ cells of WT mice at 
the other hand: the first show a much higher mobilisation of Ca2+ from the extracellular space. 
We conclude, that the Ca2+ response of cells carrying a chimeric IgE-BCR is quantitatively 
and qualitatively different from those carrying a wild type IgE-BCR 
 
The frequency of mIgE+, CXCR4low cells is increased in KN1 mice 
We next asked whether the different signalling behaviour of the WT and chimeric IgE-BCR 
could result in a different expression pattern of relevant surface receptors, e.g chemokine 
CXCR4, the receptor for CXCL12. 46.3 ± 1.2% of the CD138high, mIgE+ population in WT 
mice stained positive for CXCR4 and only a slightly enhanced CXCR4 expression (48.9 ± 
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1.1%) was measured in KN1 mice. Again, a more significant difference was observed for the 
CD138low, mIgE+ cells. While 2.8 ± 0.3% of the WT population expressed CXCR4, KN1 
derived CD138low, mIgE+ cells expressed CXCR4 with a frequency of 10.2 ± 1.4%. In 
comparison, 45.8 ± 1.6% of the CD138high, mIgG1+ and 13.5 ± 1.9% CD138low, mIgG1+ 
population expressed CXCR4. Most strikingly, the absolute number of CD138low, mIgE+ cells 
in KN1 mice was much higher than the corresponding WT population resembling the 
situation of CD138low, mIgG1+ cells (Figure 6d). This supports the data observed above: 
emerging plasmablasts of KN1 mice carry the highest number of (chimeric) mIgE and are 
thus sensitive to isotype-specific (i.e. γ1-specific) signalling.  
Summarizing, emerging plasmablasts of KN1 mice show the highest expression of the 
(chimeric) IgE-BCR, show a more γ1-like signalling pattern and express the chemokine 
receptor CXCR4 at a higher frequency, allowing them to respond to the chemokine CXCL12, 
which guides plasma cells to the bone marrow.  
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Discussion 
Compared with the other immunoglobulin classes, which are present in serum in 
concentrations of up to milligrams per millilitre, the titre of IgE ranges between nano- to 
microgram/ml in the plasma of normal healthy individuals and laboratory mouse strains. 
Although the biological function of IgE is still a matter of speculation, to date IgE is best 
known for its strong, unwanted effector functions manifesting as allergic symptoms [21]. 
These can range from local symptoms like hay fever to life-threatening systemic reactions 
culminating in anaphylactic shock, underlining the potential hazard of high systemic IgE 
titres. In the recent past others and we have described several B-cell specific control 
mechanisms that affirm a tight control of the IgE response, with the inherent biological aim to 
restrain potentially dangerous IgE responses:  
(a) IgE has the shortest free serum half-life of all immunoglobulins averaging 12 h in mice 
[22] and 1 to 5 days in humans [23, 24].  
(b) Studies with CD23-deficient mice clearly demonstrated the role of CD23 as negative 
feedback regulator of IgE production [25].  
(c) Mice lacking the ε membrane exons [15] revealed the key function of the IgE B-cell 
receptor in the regulation of the quality and quantity of IgE expression in vivo [26, 27].  
(d) Recently we published that alternative polyadenylation restricts membrane IgE expression 
and thus influences serum IgE production [28]. This latter mechanism appears to set a high 
transcriptional threshold for IgE expression. Because expression of the membrane form of IgE 
is necessary for the survival or recruitment of IgE-secreting cells, low expression of the 
mRNA for mIgE most likely limits the number of IgE-secreting cells and thereby limits the 
magnitude of an IgE-mediated immune response.  
(e) In the present manuscript we identified a further mechanism limiting the IgE response. 
Comparing WT mice with KN1 mice, in which the ε membrane exons were exchanged for 
those of γ1, leading to the production of an chimeric IgE-IgG1 BCR, we found that IgE 
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antibody secreting cells (IgE-ASCs) migrate slower towards a CXCL12 gradient than IgG1-
ASCs, a difference that was caused by a different signalling behaviour of γ1- vs ε-anchored 
BCRs.  
 In KN1 mice, IgE serum titres continually increased during life. In 8 weeks old mice 
the difference in the IgE titres between WT and KN1 mice was not significant, but 6 months 
later a 4- to 6-fold increase of serum IgE was observed. ELISpot analyses showed a 
corresponding increase in the number of IgE-ASCs. Therefore, the enhanced IgE level in 
KN1 mice was the reflection of higher numbers of IgE-secreting cells. Remarkably, IgE-
ASCs were not distributed equally between spleen and bone marrow. A significantly higher 
number of IgE-ASCs was found in the bone marrow. While IgE-ASCs detected in the spleen 
mainly belong to early and short-lived plasma cells, the IgE-secreting population found in the 
bone marrow most likely represented non-dividing, resident, long-lived plasma cells 
(reviewed in [3]). Our interpretation of this observation is that during plasma cell 
development γ1-like signalling enhances the formation of Ig-secreting plasmablasts and 
facilitates homing of these cells to the bone marrow, allowing them to become non-dividing, 
resident, long-lived plasma cells. This is reflected in KN1 mice by a greater number of IgE-
ASCs in spleen and even more in bone marrow, leading to an overall enhanced IgE response. 
This implies that IgG1 responses mature faster and are therefore much more efficient than IgE 
responses. Evidence for the latter notion was obtained when we studied the kinetics of IgE- 
and IgG1-ASC-formation in spleen and bone marrow during an immune response. In KN1 
mice, after immunisation antigen-specific IgE-ASCs were found from day 28 onwards in 
spleen and bone marrow, whereas in WT mice the first IgE-ASCs were detectable in spleen 
around day 44. Similarly, in not intentionally immunised mice, CD138+, mIgE+ cells were 
detected at a higher frequency in 8 weeks old KN1 mice than in WT mice of the same age, 
underlining that specific development of IgE-ASCs is reflected in general development of 
these cells in KN1 mice. Also precursors to plasma cells, CD138low, mIgE+ cells, were 
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detected earlier and at a higher frequency in the bone marrow of KN1 mice than in that of WT 
mice. 
 Also memory formation was affected by γ1-like signalling. After the second booster 
immunization (day 42) a far more robust rise in phOx-specific IgE antibody titre was 
measured in KN1 mice compared to wild type mice.  
 These results were not caused by an increased secretion rate of IgE-ASCs with a γ1-
like signalling history or a different rate of class switch recombination: After in vitro 
activation, there was no difference in class switch recombination towards ε in KN1 mice, as 
compared to WT mice, neither did KN1-derived IgE-ASCs produce more IgE per cell than 
did those of WT mice. Further, when comparing the secretion rate of IgE-ASCs with that of 
IgG1-ASCs, we found comparable rates. We did not expect a higher switch recombination 
rate to ε in KN1 mice, because class switch to ε is in mice an inherent feature of the Sε switch 
region, and is not influenced to a major extent by "trans-switching" from µ to γ1 to ε [29]. 
A substantive point was observed in the in vitro activated cultures of B cells: more 
CD138low, mIgE+ cells arose in the KN1 derived cultures when compared to those derived 
from WT mice. This can be explained by a more efficient recruitment of activated B cells in 
this particular cell population, or by an extended lifespan of these cells. The latter possibility 
was less likely, because we did not see an increased expression of the survival protein Bcl2 
(data not shown). Furthermore, CD138low, mIgE+ cells, which we consider to be similar to 
germinal centre B cells and precursors to memory cells and early plasmablasts, of KN1 mice 
expressed a higher number of IgE-BCRs per cell. The enhanced expression may well be 
caused by a more efficient polyadenylation of the chimeric mRNA [28] as our unpublished 
data has shown. Of course, the increased density of BCRs bore the potential of an altered, c.q. 
stronger signal raised by receptor ligation. This we could experimentally show: The signal 
generated by the chimeric, KN1-derived IgE-BCR resembled an IgG1-driven response in that 
it showed an increased, late mobilisation of Ca2+ ions from the extracellular space. However, 
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the early mobilisation from intracellular stores was similar in WT- and KN1-derived 
CD138low, mIgE+ cells, and lower than that in mIgG1-positive cells. 
Functionally, the increased expression of the chimeric IgE-BCR on CD138low, mIgE+ 
cells of KN1 mice was accompanied by an increased expression of the chemokine receptor 
CXCR4. In view of this, it is not surprising that IgE-ASCs of KN1 mice show an increased 
mobility towards the ligand of CXCR4, the chemokine CXCL12. It was reported before that 
CXCR4 expression alone does not necessarily predict a more efficient migration behaviour 
[30] of ASCs. Currently, we therefore cannot exclude that factors activated in an isotype-
specific fashion and different from CXCR4 further explain our observations. Because similar 
results were obtained when comparing the mobility towards a CXCL12 gradient of IgG1-
ASCs and IgE-ASCs, we conclude that γ1-like signalling prepares early plasmablasts better 
for reactivity towards the chemokine CXCL12 than does ε-like signalling, giving 
plasmablasts with a γ1-like signalling history an competitive edge over those with an ε-like 
signalling history in their quest for niches in the bone marrow. 
In our experiments we have used a BCR-independent activation of B cells (LPS and 
IL-4), albeit after ligation of the BCR with anti-IgM antibodies, used in the enrichment 
procedure of B cells. We assume, that in a normal immune response, the B cell is triggered by 
its nominal antigen, an interaction, which is probably of a low affinity character. Therefore, 
our activation schedule may well be of physiological nature. We assume that after activation, 
the B cell proceeds on its differentiation pathway independently of the initiating cue, most 
likely helped in vitro by various autoantibodies, that are induced upon polyclonal stimulation.  
More significantly, our in vitro data are mirrored and corroborated by in vivo observations. 
Our data lead to the following conclusions: 
1. γ1-like signalling by the chimeric receptor during all times of the germinal centre reaction 
in KN1 mice leads to a higher number of (chimeric) IgE specific memory B cells or to a more 
efficient recruitment of B cells with a chimeric receptor to the pool of IgE-secreting plasma 
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cells. These hypotheses are not mutually exclusive, but both focus on the fact that the 
exchange of the ε transmembrane and cytoplasmic domains of mIgE with those of γ1 in KN1 
mice influences the magnitude and quality of the IgE immune response and recall the notion 
that IgG1 memory responses in WT mice are superior over IgE memory responses [27]. 
Similar conclusions, comparing IgG1 and IgM responses, were suggested by Martin et al. 
[18]. In their study, a transgenic expression of γ1 or µ/γ1 hybrid chains led to an enhanced 
generation of memory and plasma cell progeny upon antigenic challenge [17, 18]. By means 
of transfer experiments Martin et al. could perfectly dissect whether their observations were 
the result of a more efficient generation of memory or plasma cells, or a more efficient 
survival of them. Based on expression levels of Bcl2, which is the same in mIgE+ cells 
derived from WT or KN1 mice, we believe we can exclude different survival rates determined 
by either the normal or the chimeric IgE-BCR. Unfortunately, the cell number for IgE 
expressing cells, also after immunizations, were too low to perform meaningful transfer 
experiments. 
2. BCR-mediated signalling continues in the plasmablast stage and has an isotype-specific 
component: γ1-like signalling by the chimeric receptor leads to a specific expression pattern, 
exemplified by the expression of the chemokine receptor CXCR4. Reactivity to its ligand 
CXCL12 gives the plasmablasts with a γ1-like signalling history a competitive edge over 
those with an ε-like signalling history. 
  Our observations, also leads to the conclusion that during a Th2-mediated immune 
response, in normal, WT mice, IgE plasmablasts have an intrinsic, lower chance to contribute 
to the long-lived plasma cell pool and thus to humoral immunologic memory than IgG1 
plasmablasts. Apparently, an IgE immune response is in all stages of the response less 
efficiently regulated, leading to a poor response. The IgE antibodies may have strong effector 
functions, but the IgE response is slow and limited in developing memory responses. 
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 Materials and methods 
 
Construction of mouse strain KN1 
The γ1 gene was isolated by PCR using genomic DNA of BALB/c ES-cells as template. The 
sense-primer (5´GTCCTGGTGATTTCTGAGAT3´) was located 3´ to spoly(A). The 
antisense-primer (5´GTGGAGGACAGACTGAGGACC3´) was located 3' of the mpoly(A). 
The target vector pKN1 (Figure 2a) consists of 8745 base pairs (bp) of genomic DNA, 
starting inside CH3 of the ε gene. A BamH1 site was inserted 3' to spoly(A). The ε-membrane 
locus (ranging from 3' of spoly(A) to 3´of the third cryptic "membrane" poly(A) site) was 
replaced by the γ1-membrane locus (3686bp), followed by additional 1000bp of ε-genomic 
sequence. The herpes simplex virus thymidine kinase gene (HSV-Tk) was inserted 5´of CH3. 
For positive selection a neomycin resistance gene, expressed by a thymidine kinase promoter 
(Tk-NEO), was inserted. BALB/c ES cells were transfected with 30 µg of linearized target 
vector and cultured and selected as described before [15, 31]. Resistant clones were screened 
by nested PCR with primer combination 257-258 and 259-260: 
257: 5´AGTTGGCCTTTTCTGGGTTCT3´  
258: 5´ATGGCCGCTTTTCTGGATTC3´ 
259: 5´CAACTACGCCCCGGAGCCATCAG3´ 
260: 5´CGCATCGCCTTCTATCG3´ 
Positive targeting events were confirmed by Southern blotting, using a 5´external, a 3´external 
and a neo probe (Figure 2b). Positive ES-cell clones were injected in C57/Bl6 blastocysts. 
Chimeric mice were bred for heterozygocity and later on for homozygocity. Genotypes were 
finally confirmed by Southern blot analysis. 
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Enzyme-Linked ImmunoSorbent Assay, activation of spleen cells with LPS and IL-4 
Spleen cells were activated with LPS and IL-4 as described elsewhere [32]. The ELISA assay 
for IgE was performed as described before [15, 26, 31].  
 
ELISpot-Analysis 
Single cell suspensions from bone marrow and spleen were filtered through a 70µm cell 
strainer and re-suspended in RPMI 1640 medium supplemented with 10% FCS. 
MultiScreenTM-IP (Millipore) plates were coated with rat α-mouse IgE, rat α-mouse IgG1 or 
OVA and incubated over night with defined numbers of spleen cells in RPMI medium. 
Antibodies for coating and detection are described in [15]. Spots were detected with 
NBT/BCIP (Roche) tablets.  
 
FACS analysis 
Spleen- and bone marrow cells were isolated and erythrocyte lysis was performed. To remove 
CD23-bound IgE, cells were incubated with ice-cold stripping buffer (0,05M NaAcetate, 
0,01M EDTA, 0,005M KCl, 0,085M NaCl, pH=4) for 1 minute. Antibodies used were rat 
anti- CD184(CXCR4), -CD138, -IgE(R35-72), -CD45R(B220) (all BD-Pharmingen, labels 
are indicated in the Figures). Appropriate isotype controls (all BD-Pharmingen) were used. 
Dead cells were excluded by 7-AAD staining. Data were acquired with a CANTO II device 
(BD) and analyzed with FlowJo 8.5.3.  
 
Transwell migration assay 
Spleen cells of were enriched for IgM-positive cells using a FITC-labelled rat α-mouse IgM 
antibody, followed by a separation with magnetically labelled α-FITC beads. Subsequent 
FACS analysis showed enrichment for IgM-positive cells of 99%. Afterwards these cells were 
activated with LPS and IL4, inducing class switch to IgG1 and IgE. Equal numbers of 
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activated cells were then seeded onto transwell plates. The migration assay was performed 
according to Hauser et al. [33]. Migration towards the ligands mouse CXCL12/SDF-1a (460-
SD Biomedica) and mouse CXCL9 (492-MM Biomedica) at 10nM and 100nM concentration 
was analyzed. After 90 min, migrated ASCs were distributed onto 10 wells and ELISpot 
detection was performed. For CXCL12 we also tried concentrations of 1nM and 50nM. 
However, with 1nM no migration was observed with 50nM we observed the same migration 
frequency as with 10nM. 
 
Immunization protocol with phOx-OVA 
5 WT and 5 KN1 mice were immunized subcutaneously (sc) with 20µg of phOx11-OVA 
precipitated in alum with Bordetella pertussis (1x107). 14, 21, 42 and 181 days later, the mice 
received a booster immunization with 20 µg of phOx11-OVA sc and 20 µg of phOx11-OVA 
intraperitoneally (ip). Serum was taken at day 0 (d0), d7, d14, d21, d28, d42, d49, d181 and 
d188. Individual serum samples were used to detect total and phOx-specific IgG1 and IgE 
antibodies with ELISA.  
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Figure Legends 
 
Figure 1:  
Migration assay of IgE- and IgG1-ASCs. 
IgG1-ASCs and IgE-ASCs were exposed to the chemokine CXCL9 and CXCL12 in a 
Transwell culture plate and their migratory behaviour was tested (see also Supp. Fig. 1). 
Figure 1 summarizes a three times repeated experiment with the individual analysis of 3 WT 
mice each. Potentially migrating cells of each subclass were counted by ELISpot and set as 
100%. Using the paired t-test, statistical significance at the level of *p< 0.05 and **p< 0.001 
was calculated. 
 
Figure 2:  
IgE serum levels, ELISpot and flowcytometric analysis of bone marrow and spleen of 
WT and KN1 mice. 
(a) Total serum IgE levels of 8 weeks and 8 months old 5 WT and 5 KN1 mice. 
(b) ELISpot analysis of IgE-ASCs originating from pooled spleen and bone marrow cells 
from 5 WT and 5 KN1 mice. For statistical analysis, IgE-ASCs were determined individually 
and extrapolated for 106 spleen or bone marrow cells. Values are means ± SD of five mice per 
time point. Figure 2ab summarizes a three times repeated experiment with the individual 
analysis of 5 WT mice each (*p< 0.05; **p< 0.001; ***p< 0.0001). 
(c) Flowcytometric analysis of bone marrow cells of 8 weeks and 6 months old WT and KN1 
mice. Bone marrow cells were incubated with ice-cold stripping buffer followed by 
incubation with rat anti-CD138 and rat-anti IgE. Cells were pregated for living lymphocytes. 
The lower cutoff value for mIgE positive cells was determined with corresponding isotype 
controls (see Fig. 6b).  
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Figure 3: 
In vitro differentiation potential of activated IgM+ cells of WT and KN1 mice. 
In vitro activated IgM+ cells of WT and KN1 mice were cultured for 2 and 4 days with LPS 
and IL4.  
(a) Supernatants were analysed for IgE and IgG1 content by ELISA.  
 (b) Cells were analysed for IgE and IgG1 secretion by ELISpot. Values for a and b are means 
± SD of three independent experiments with three mice each. 
 
Figure 4:  
Time course of immunization I.  
5 WT and 5 KN1 mice were immunized with the T-cell dependent antigen phOx-OVA at day 
0, 14, 21, 42 and 181. Immunoglobulin levels were measured by ELISA. (a) total serum IgG1. 
(b) phOx-specific IgG1. (c) total IgE. (d) phOx-specific IgE. Values are means ± SD of three 
immunizations with five mice per time point. p-values for time points d42, d49, d181 and 
d188 for total and specific IgE were significant (*p< 0.05 and **p< 0.001). 
 
Figure 5:  
Time course of immunization II.  
5 WT and 5 KN1 mice were immunized with OVA. IgE- and IgG1-ASCs of spleen and bone 
marrow were detected with ELISpot assays. The total and specific humoral IgE response at 
day 28 of KN1 mice was significantly upregulated in the spleen (e,g) and even more in the 
bone marrow (f,h). Corresponding measurement of IgG1-ASCs (a-d) served as control. 
Values are means ± SD of three immunization experiments with five mice per time point. 
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Figure 6:  
Transwell migration assay of WT and KN1 derived IgE-ASCs / Evaluation of the 
surface co-expression of mIgE , CD138 and CXCR4 and functional activity of CD138low, 
mIgE(mIgG1)+ cells 
(a) Summary of a three times repeated experiment with the individual analysis of the 
migration frequency of 3 WT and 3 KN1 mice towards CXCL12. Values are means ± SD 
(**p< 0.001). 
 (b) To visualize mIgE+ populations co-expressing CD138, 2x106 activated lymphocytes were 
acquired. The lower cutoff value for mIgE positive cells was determined with corresponding 
isotype controls and competition stainings. Numbers in the quadrants represent % of the cell 
populations. 
(c) Ca2+ fluxes of CD138low, mIg+ B cells (see Quadrant Q3 of Figure 6b) 
(d) CD138low, mIgE+ and CD138high, mIgE+ populations were gated and further analyzed for 
CXCR4 expression.  
 






